Mon, 05/06/2019 - 12:37
On May 6th, 2019, Vivimed Life Sciences announced a recall of 19 lots of Losartan tablets (25mg, 50mg, and 100mg) due to the detection of an unexpected impurity (NMBA) found in the active pharmaceutical ingredient. The recalled products were distributed by Heritage Pharmaceuticals.
Additional information is available on the FDA's website:
Last updated: Thu, 09/05/2019 - 14:09